Skip to content
Trial Eligibility
Menu

100-Year Human Aging Study

NCT07563777

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The 100-Year Human Aging Study is a prospective, pragmatic, observational trial enrolling participants across fixed clinical sites, mobile clinical sites, and an online participation pathway (current and future) to undergo comprehensive multi-system health screening and longitudinal follow-up until death. Participants are followed to determine whether measurements taken at enrollment and repeated across the lifespan - individually and in combination - predict all-cause mortality, cause-specific mortality, incident serious disease, and functional disability.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Aging
  • Aging Well
  • All-Cause Mortality
  • Mortality
  • Metabolic Syndrome
  • Cardiovascular Diseases
  • Cognitive Dysfunction
  • Musculoskeletal Diseases
  • Neoplasms
  • Frailty
  • Activities of Daily Living
  • Health-Related Quality of Life
  • Disability Physical
  • Neuro-Degenerative Disease
  • Dementia

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Longevity Metrics, Inc.
Last updated on ClinicalTrials.gov
September 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • Longevity Metrics · Boulder, CO

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.